---
title: "PEGBIO voluntarily dissolves its subsidiary Shanghai MaiJi to focus on core business and streamline operations"
description: "PEGBIO CO announced that it has applied for the voluntary dissolution of its non-wholly-owned subsidiary, Shanghai MaiJi. The company stated that Shanghai MaiJi is engaged in the research and developm"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/263979622.md"
published_at: "2025-11-03T09:29:43.000Z"
---

# PEGBIO voluntarily dissolves its subsidiary Shanghai MaiJi to focus on core business and streamline operations

> PEGBIO CO announced that it has applied for the voluntary dissolution of its non-wholly-owned subsidiary, Shanghai MaiJi. The company stated that Shanghai MaiJi is engaged in the research and development of the peptide hormone GLP-2, and the dissolution is aimed at focusing on core business and streamlining operations. After the dissolution, the company will continue to develop its core products in the fields of metabolism and weight loss treatment. Therefore, the dissolution will not have an adverse impact on the overall business operations and financial condition of the company or the group

PEGBIO CO (02565.HK) announced that it has applied for voluntary dissolution of its non-wholly-owned subsidiary Shanghai MaiJi. The company stated that Shanghai MaiJi is engaged in the research and development of the peptide hormone GLP-2, and the dissolution is aimed at focusing on core business and streamlining operations. After the dissolution, the company will continue to develop its core products in the fields of metabolism and weight loss treatment. Therefore, the dissolution will not have an adverse impact on the overall business operations and financial condition of the company or the group

### Related Stocks

- [02565.HK - PEGBIO CO-B](https://longbridge.com/en/quote/02565.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Lindora Appoints JJ Virgin as Chief Metabolic Health Officer to Lead Proprietary “Muscle-First: Everything Else Follows” Programming | Lindora has appointed JJ Virgin as Chief Metabolic Health Officer to lead its new "Muscle-First: Everything Else Follows | [Link](https://longbridge.com/en/news/276184767.md) |
| 13:58 ETDr. Marcus Goncalves Named Director of NYU Langone's Holman Division of Endocrinology, Diabetes, & Metabolism | Dr. Marcus D. Goncalves has been appointed as the new director of the Holman Division of Endocrinology, Diabetes, and Me | [Link](https://longbridge.com/en/news/276368897.md) |
| ZAWYA-PRESSR: AEON Clinic leads the future of male and female longevity through regenerative medicine | AEON Clinic in Dubai is pioneering longevity science through its Regenerative Medicine approach, addressing the unique b | [Link](https://longbridge.com/en/news/276031879.md) |
| Green Impact Partners Commences Court-Supervised Process to Facilitate Refinancing and Strategic Transactions \| GIPIF Stock News | Green Impact Partners Inc. (TSXV: GIP) has initiated a court-supervised process under the Companies' Creditors Arrangeme | [Link](https://longbridge.com/en/news/276269163.md) |
| 08:42 ETHanyang University ERICA Researchers Identify Key Mechanism Driving Progression of Fatty Liver Disease to Cancer | Hanyang University ERICA researchers have identified key mechanisms linking endoplasmic reticulum (ER) stress and the un | [Link](https://longbridge.com/en/news/276060512.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.